Patterns of medication use in the RRI-CKD study: focus on medications with cardiovascular effects
about
sameAs
Underuse of American College of Cardiology/American Heart Association Guidelines in hemodialysis patientsAwareness and knowledge among internal medicine house-staff for dose adjustment of commonly used medications in patients with CKDQuality of Care for Patients With Chronic Kidney Disease in the Primary Care Setting: A Retrospective Cohort Study From Ontario, CanadaThe impact of renal protection clinics on prescription of and adherence to cardioprotective drug therapy in chronic kidney disease patients.Characterizing pre-dialysis care in the era of eGFR reporting: a cohort studyRecommendations for the assessment and reporting of multivariable logistic regression in transplantation literature.Potential role of differential medication use in explaining excess risk of cardiovascular events and death associated with chronic kidney disease: a cohort studyMedication adherence behavior and priorities among older adults with CKD: a semistructured interview study.Nondisease-specific problems and all-cause mortality among older adults with CKD: the REGARDS StudyCardiorenal syndrome type 4-cardiovascular disease in patients with chronic kidney disease: epidemiology, pathogenesis, and management.Kidney function and long-term medication adherence after myocardial infarction in the elderlyLipid levels and renal function decline in pre-dialysis patients.Utilization Patterns of IV Iron and Erythropoiesis Stimulating Agents in Anemic Chronic Kidney Disease Patients: A Multihospital Study.Using pharmacists to improve risk stratification and management of stage 3A chronic kidney disease: a feasibility study.Treatment of hypertension and diabetes mellitus in patients with chronic kidney disease: a review.Epoetin therapy and hemoglobin level variability in nondialysis patients with chronic kidney diseasePrescribing pattern of medicines in chronic kidney disease with emphasis on phosphate binders.Pharmaceutical cost distribution in childhood chronic kidney disease.Drug adherence in chronic kidney diseases and dialysis.Process quality indicators for chronic kidney disease risk management: a systematic literature review.Telemedicine to Promote Patient Safety: Use of Phone-Based Interactive Voice-Response System to Reduce Adverse Safety Events in Pre-dialysis CKD.Prescribing patterns of medicines in chronic kidney disease patients on maintenance hemodialysis.Attributable causes of chronic kidney disease in adults: a five-year retrospective study in a tertiary-care hospital in the northeast of the Malaysian Peninsula.Prevalence and management of anemia in pre-dialysis Malaysian patients: A hospital-based study.Sex Hormone Status in Women With Chronic Kidney Disease: Survey of Nephrologists' and Renal Allied Health Care Providers' Perceptions.Symptom Management of the Patient with CKD: The Role of Dialysis.The Landscape of Diabetic Kidney Disease in the United States.Major barriers against renin-angiotensin-aldosterone system blocker use in chronic kidney disease stages 3-5 in clinical practice: a safety concern?
P2860
Q28218895-0F438F06-11B6-449B-9099-8F7817093C17Q28468296-61C5CEF0-5E80-49CE-B256-C1E901F23F9EQ33772228-DC5741DE-E8C7-4173-93C2-832726CDE0C8Q33783149-EF7D14AB-9EA3-4F3D-A394-CA1628FEA530Q33846660-0C11F2F5-6A75-4565-96DC-AE80E2241C28Q34015754-6E825128-1C7F-4832-9DD3-796E0C1BCDDDQ34019491-DECFB566-DE9C-490E-BEF5-1BC7C6B5B09CQ34109930-0AF8ECC7-6805-4737-A0F4-D6B160231731Q34292815-749AC3CE-34AC-4EBF-93DF-6D1296DEBDFBQ34572435-5DB2EBF0-84A8-4B5A-9019-96ED9B54B064Q34751920-428328B6-788D-434C-889F-DBDA4B37DF91Q35204390-CDDDC2FC-899C-4492-9AB2-451847EFE43AQ35936604-B8DFB640-70AA-4772-BD42-1975B96C7489Q36185991-2A18192A-2ECC-4D05-ABFF-B3172095846EQ36968170-37B10410-65AC-44EA-97CD-3B87EED6172FQ37123211-81AF88B5-7DC7-49FD-A937-3C1291895DE8Q37551497-E639B3A3-97F0-4395-9A9A-41A91032484BQ38006631-ACF51EC4-0AA6-4FC9-BE7D-E4D6A84E957DQ38187107-5E855451-2EC4-436E-9847-EF2A86F7A961Q38957924-DF4BF191-8DDE-4B3D-93F4-6435EEAB6C34Q39146364-A47A5FE2-2AFD-4E66-9FB0-8C540E44C2B8Q39307527-69F2DFDC-1B5E-45DE-B144-6CD6AEC70C84Q40114845-567B9380-9C66-49BC-8CF2-A6DC41E65FCEQ40418454-2380BA5C-B368-4187-BB16-ADE7C0715B6AQ45790710-27C5817E-4872-4334-B000-6C6575FC3B9CQ47581119-75686A72-412F-4B7B-9618-3661DC3603DDQ49862755-6C35F5B6-468A-436D-968A-386BA81AF8B3Q50914167-3E8269DB-575B-49E5-8C48-C2457995318E
P2860
Patterns of medication use in the RRI-CKD study: focus on medications with cardiovascular effects
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Patterns of medication use in ...... ns with cardiovascular effects
@ast
Patterns of medication use in ...... ns with cardiovascular effects
@en
Patterns of medication use in ...... ns with cardiovascular effects
@nl
type
label
Patterns of medication use in ...... ns with cardiovascular effects
@ast
Patterns of medication use in ...... ns with cardiovascular effects
@en
Patterns of medication use in ...... ns with cardiovascular effects
@nl
prefLabel
Patterns of medication use in ...... ns with cardiovascular effects
@ast
Patterns of medication use in ...... ns with cardiovascular effects
@en
Patterns of medication use in ...... ns with cardiovascular effects
@nl
P2093
P3181
P356
P1476
Patterns of medication use in ...... ns with cardiovascular effects
@en
P2093
Frederick Finkelstein
Friedrich Port
George Eisele
George R Bailie
Margaret Kiser
Rajiv Saran
Robert Wolfe
Sally Burrows-Hudson
P304
P3181
P356
10.1093/NDT/GFH771
P407
P577
2005-06-01T00:00:00Z